All News

Currently, blood-thinning medications are only prescribed to patients who have already had a heart attack or stroke, as the drugs can cause serious bleeding.

The drug is the first rapid-acting insulin biosimilar product approved for use by the FDA, marking a significant milestone in diabetes treatment.

Identifying women who are at risk for postpartum depression sooner can lead to quicker and possibly preventative treatment.

Among providers who took part in a recent study, 57% reported increased vaccination rates after implementing a quality improvement initiative.

Investigators note there were no safety signals related to the vaccine candidate, and participants who developed E. coli disease received treatment and care.

What are some key strategies for keeping your pharmacy thriving in 2025?

A dose response is observed with the highest dose of the drug and mitigating withdrawal symptoms for patients with cannabis use disorder.

Pharmacy industry experts gathered for a webinar detailing the upcoming trends expected to take shape in 2025.

More detailed information can be found on the CDC’s website at www.cdc.gov/vaccines.

Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.

A discussion on the new nonopioid selective NaV1.8 pain signal inhibitor with Madison Irwin, PharmD, BCPS.

For patients with atopic dermatitis reporting moderate-to-severe scratching, researchers explored the efficacy of an AI-enabled wearable sensor with closed-loop haptic feedback.

Multiple micronutrient supplements showed the greatest impact on reducing the risk of giving birth to small vulnerable newborns.

The tablet formation of risdiplam (Evrysdi) demonstrates bioequivalence to the oral formulation of the drug.

The designation is based on the AMULET phase 2 trial, which was the first-in-human study of the drug.

Those who contributed to the arrest of Luigi Mangione, the suspect in the murder of UnitedHealthcare CEO Brian Thompson, are facing unjustified backlash. They are heroes—not snitches.

Cardiovascular health is known to be associated with the probability of having active or developing migraine in the future.

Data has shown the investigational cell therapy is well-tolerated in patients and showed preliminary impacts on cognition.

Recently, there has been concern around glucagon-like peptide-1 receptor agonists and increase the risk of thyroid cancer, with liraglutide having a black box warning label for the disease.

Crystal Zhou, PharmD, APh, AHSCP, BCACP, discussed her role as Lead Pharmacist of the Cut Hypertension Program.

Madison Irwin, PharmD, BCPS, discusses the importance of suzetrigine’s approval in the pain management space and potential challenges or barriers in its adoption.

Tryvio was given FDA approval on March 19, 2024.

Help your patients overcome tummy troubles with trusted OTC products that relieve bloating, heartburn, and more, promoting smooth and happy digestion.

Researchers conducted a review of clinical studies to better understand non-oral drugs for the treatment of pain related to herpes zoster.

Social media can help close the gap on health care information access, but pharmacists still play a large role in diabetes management, especially in therapeutics.

Poor cardiometabolic health is associated with cognitive impairment in later life, but there is no clear association between cardiometabolic trajectories and early markers.

Natalie DiPietro Mager, PharmD, PhD, discusses the best ways to integrate maternal health services into the routine workflow of community pharmacies.

Researchers asked adults with chronic pain and physicians their opinions on cannabis regulations.